Home › Cytokine Release Syndrome › Pennsylvania
Cytokine Release Syndrome clinical trials in Pennsylvania
3 studies for Cytokine Release Syndrome are looking for participants at sites in Pennsylvania.
Hemophagocytic Lymphohistiocytosis (HLH) Evaluation and Research of Clinical, ImmUnoLogic and TranscriptomE Study
- University of Pittsburgh, Pittsburgh
RecruitingObservational study
Ages 18 to 120 · All sexes · Updated Sep 10, 2026 · NCT06339177Study of CTO1681 for the Prevention and Treatment of CRS in Patients Receiving CAR T-Cell Therapy
- University of Pittsburgh Medical Center, Pittsburgh
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 31, 2026 · NCT05905328Tadekinig Alfa (IL-18BP) Rescue Therapy for CAR T Cell Related Cytokine Release Syndrome (CRS) and HLH-like Syndrome
- University of Pennsylvania, Philadelphia
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Mar 3, 2026 · NCT05306080From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.